Aarey Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results
Aarey Drugs & Pharmaceuticals Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Aarey Drugs Schedules Board Meeting to Approve Q2 FY27 Financial Results Aarey Drugs & Pharmaceuticals Ltd. has scheduled a Board of Directors meeting for 14th Nov'26 to consider and approve the unaudited financial results alongside the limited review report for the quarter and half-year ended 30th Sep'26. In compliance with SEBI Insider Trading regulations, the company's trading window closed on 1st Oct'26 and will remain shut until 48 hours following the formal announcement of the financial results.
Original exchange filing (PDF)
More announcements from Aarey Drugs & Pharmaceuticals Ltd
- Statement of deviation and variation for the quarter ended September 30, 2026 路 15 Nov 2026
- As per attachment 路 15 Nov 2026
- 1. The Board of Directors of the Company has considered and approved the Standalone Unaudited Financial Results for the second quarter & half year ended on 30th September, 2026 along with .... 路 15 Nov 2026
- Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Aarey Drugs and Pharmaceuticals limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 14 Nov 2026
- Revised outcome 路 07 Oct 2026
- Scrutinizers Report of 36th Annual General Meeting 路 06 Oct 2026
